ENLIGHT-LN REGISTRY
Live / Registered — Registered (as of 30 Apr 2024)
What this means for you
Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97253202
- Registration number
- 7375165
- Mark type
- Stylized text
- Filed
- 04 Feb 2022
- Published for opposition
- 04 Jul 2023
- Registered
- 30 Apr 2024
- Attorney of record
- Matthew R. Wilmot
Goods and services
- Class 042 — Scientific and technological services: Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis
Owner
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
Prosecution history
- 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Feb 2024 — USE AMENDMENT FILED
- 21 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 31 Aug 2023 — ASSIGNED TO EXAMINER
- 29 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jul 2023 — PUBLISHED FOR OPPOSITION
- 14 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED